$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
FDA授予套细胞淋巴瘤的VLS-101疗法快速通道资格和孤儿药资格认定
2025-10-19 11:44:20
Check Details
Tecartus获FDA批准用于治疗复发或难治性套细胞淋巴瘤
2025-10-19 11:44:20
Check Details
FDA授予治疗T细胞淋巴瘤的Tolinapant孤儿药认定资格
2025-10-19 11:44:20
Check Details
CAR-T细胞疗法Yescarta申请用于治疗淋巴瘤
2025-10-19 11:44:20
Check Details
FDA审查治疗复发或难治性滤泡性淋巴瘤和边缘区淋巴瘤的Axi-Cel生物制剂许可证申请
2025-10-19 11:44:20
Check Details
在实际应用中受益:同时使用类固醇和Mogamulizumab可使MF/SS有更大的反应率
2025-10-19 11:44:20
Check Details
伊鲁替尼和Venetoclax作为MCL一线联合用药正在研究中
2025-10-19 11:44:20
Check Details
纳武单抗功效与作用
2025-10-19 11:44:20
Check Details
FDA批准治疗复发/难治性弥漫性大B细胞淋巴瘤的Loncastuximab tesirine的生物制剂许可证申请
2025-10-19 11:44:20
Check Details
新药selinexor(塞利尼索)治疗复发性或难治性弥漫大B细胞淋巴瘤相关说明
2025-10-19 11:44:20
Check Details
FDA对克唑替尼(Crizotinib)治疗复发/难治性ALK阳性ALCL给予优先审查
2025-10-19 11:44:20
Check Details
普乐沙福对非霍奇金淋巴瘤有效果吗?
2025-10-19 11:44:20
Check Details
1
2
...
1217
1218
1219
1220
1221
1222
1223
...
4157
4158
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
2
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
3
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
4
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
5
Cabozantinib Capsules: A Multi-Targeted Therapy for Progressive Medullary Thyroid Cancer
6
Lorlatinib: Mechanism, Advantages, and Key Considerations of Third-Generation ALK Inhibitor Therapy in ALK-Positive NSCLC
7
Pemigatinib Side Effects Explained: Managing Adverse Reactions of FGFR-Targeted Therapy in Cholangiocarcinoma
8
Selpercatinib: Before or After Meals? A Complete Guide to RET-Targeted Therapy Administration
9
Mitotane for Adrenocortical Carcinoma: Dosing Guidelines and Therapeutic Drug Monitoring
10
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
11
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)
12
Chemical Structure of Capivasertib: A Novel AKT Inhibitor